 | Chemomab Therapeutics Ltd. | |||
| NasdaqCM : CMMB || Location: Israel | ||||
$3.455-0.24 (-6.37%) |
0.03 M | 3.38 - 3.755 | ||
| Last Updated:08/09/2022 15:49 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 15, 2022 | 0.005 M |
| June 30, 2022 | 0.022 M |
| June 15, 2022 | 0.009 M |
| May 31, 2022 | 0.011 M |
| May 13, 2022 | 0.008 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2022 | -0.24 | -0.44 | -83.30% |
| 12/31/2021 | -0.10 | -0.44 | -340.00% |
| 09/30/2021 | -0.14 | -0.26 | -85.70% |
| 06/30/2021 | -0.11 | -0.26 | -136.40% |
| 03/31/2021 | -0.43 | -0.22 | 48.80% |
CMMB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 11.405M | Shares Float | 4.975M |
| Short Float | 0.005M | Market Cap | 39.92M |
| Institution ownership | 35.51% | Insider ownership | 26.032% |
| Earnings Date | 08/12/2022 BMO | Cash Per Share | ? |
| Trailing EPS | -1.41 | Forward EPS | -2.59 |